InCrowd, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
InCrowd, Inc. - overview
Established
2010
Location
Watertown, MA, US
Primary Industry
Information Services
About
InCrowd, Inc. revolutionizes healthcare market research by utilizing an intelligent platform that connects researchers with diverse healthcare audiences through advanced technology, enhancing data collection and analysis efficiency. Founded in 2010, InCrowd, Inc. is based in Watertown, US, providing innovative solutions for healthcare market research.
The company has been involved in 5 deals, with the most recent deal occurring on August 14, 2019, when Saroras Private Capital acquired a majority stake. The company has raised a total of USD 2. 17 mn through various funding rounds, with the most recent being a Venture Debt round amounting to USD 0. 30 mn.
The CEO, Daniel Fitzgerald, continues to lead the company as it evolves in the competitive healthcare research market. InCrowd offers the Konovo Intelligent Platform, formerly known as InCrowd, which streamlines healthcare market research by providing direct access to a wide array of healthcare audiences. The platform incorporates advanced technology, including AI, to facilitate effective data collection and analysis. Its core offerings include the Konovo Intelligent Platform and Custom Audiences, previously known as Survey Healthcare Global, catering to market research agencies, consultancies, and biopharma companies across North America, Europe, and Asia.
InCrowd generates its revenue through a subscription-based model and partnerships with market research agencies and biopharma companies. Clients typically subscribe annually to access the Konovo platform and its comprehensive tools for conducting healthcare research. The B2B structure allows agencies and consultancies to leverage InCrowd’s platform to gain insights from engaged healthcare audiences, forming a foundational aspect of their research processes. Following the acquisition in August 2019, InCrowd, Inc.
aims to accelerate its strategic growth and enhance its business insights within the life sciences sector. The company is focusing on expanding its global reach and may target new markets in Asia and Europe by 2024. The recent funding will facilitate these initiatives and support the development of upcoming products and enhancements to the existing platform.
Current Investors
Saroras Private Capital, Launchpad Venture Group, Walnut Venture Associates
Primary Industry
Information Services
Sub Industries
Market Research & Consulting, Information Services
Website
www.incrowdnow.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
InCrowd, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.